Inventor
BOWLIN TERRY L
US12 patents
⚠️ This page may combine multiple inventors who share the name “BOWLIN TERRY L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERRELL DOW PHARMA
5 patentsUS5013719AMay 7, 1991
Method of effecting immunosuppression
MERRELL DOW PHARMA23 citations92
US5002879AMar 26, 1991
Treatment of tumors with autologous LAK cells, interleukin-2 and an ornithine decarboxylase inhibitor
MERRELL DOW PHARMA28 citations92
US5109024AApr 28, 1992
Polyamine derivatives as antineoplastic agents
MERRELL DOW PHARMA46 citations89
US5308837AMay 3, 1994
5'-amine substituted adenosine analogs as immunosuppressants
MERRELL DOW PHARMA8 citations73
US5004746AApr 2, 1991
Anti-retroviral castanospermine esters
MERRELL DOW PHARMA15 citations73
MERRELL PHARMA INC
4 patentsUS5719193AFeb 17, 1998
Method of potentiating cell-mediated immunity utilizing polyamine derivatives
MERRELL PHARMA INC26 citations92
US5646124AJul 8, 1997
Method of treating cancer by conjunctive therapy with N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent
MERRELL PHARMA INC5 citations73
US5635218AJun 3, 1997
Method of treating cancer by conjunctive therapy with N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent
MERRELL PHARMA INC6 citations73
US5561136AOct 1, 1996
Method of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent
MERRELL PHARMA INC2 citations62